StockData
EVFMOTCPharmaceutical PreparationsFiscal year ends December 31

Evofem Biosciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026

Market cap
$865.23K
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns Evofem Biosciences's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
HUB Cyber Security Ltd.14,709,2049.99%13D (active)Jun 30, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Yan Zhang
CFO
Jan 12, 2024Sale−104$0.04$40
Kim P. Kamdar
Director
Dec 21, 2023Sale−10$0.62$60
Justin J. File
Chief Financial Officer
Dec 31, 2022Returned to company−30,000––24,065
Saundra L. Pelletier
Chief Executive Officer, Director
Dec 31, 2022Returned to company−50,000––186,722
Saundra L. Pelletier
Chief Executive Officer, Director
May 27, 2022Buy+141,000$0.35$49.35K236,722
Justin J. File
Chief Financial Officer
Feb 18, 2022Award+450,000––810,982
Alexander A. Fitzpatrick
General Counsel and Secretary
Feb 18, 2022Award+300,000––516,422
Saundra L. Pelletier
Chief Executive Officer, Director
Feb 18, 2022Award+750,000––1,435,837
Justin J. File
Chief Financial Officer
Dec 31, 2021Returned to company−120,000––360,982
Alexander A. Fitzpatrick
General Counsel and Secretary
Dec 31, 2021Returned to company−120,000––216,422
Saundra L. Pelletier
Chief Executive Officer, Director
Dec 31, 2021Returned to company−300,000––685,837
Alexander A. Fitzpatrick
General Counsel and Secretary
Dec 20, 2021Buy+25,000$0.39$9.75K336,422
Saundra L. Pelletier
Chief Executive Officer, Director
Dec 20, 2021Buy+135,000$0.38$51.30K985,837
Justin J. File
Chief Financial Officer
Dec 20, 2021Buy+40,594$0.37$15.02K480,982
Russell Barrans
Chief Commercial Officer
Jul 8, 2021Tax withholding−19,998$0.98$19.60K448,554
Kim P. Kamdar
Director
Jun 18, 2021Buy+10,000$1.17$11.70K19,287
Anthony Stephen O'Brien
Director
Jun 14, 2021Buy+8,140$1.31$10.66K8,140
Lisa Dale Rarick
Director
Jun 11, 2021Buy+5,000$1.20$6.00K10,250
Russell Barrans
Chief Commercial Officer
Jun 11, 2021Buy+18,180$1.14$20.73K468,552
Alexander A. Fitzpatrick
General Counsel and Secretary
Jun 10, 2021Buy+10,000$1.03$10.30K311,422
Justin J. File
Chief Financial Officer
Jun 10, 2021Buy+24,500$1.03$25.24K440,388
Saundra L. Pelletier
Chief Executive Officer, Director
Jun 10, 2021Buy+50,000$1.03$51.50K850,837
Justin J. File
Chief Financial Officer
May 20, 2021Tax withholding−42,280$0.86$36.36K415,888
Saundra L. Pelletier
Chief Executive Officer, Director
May 20, 2021Tax withholding−105,300$0.86$90.56K800,837
Alexander A. Fitzpatrick
General Counsel and Secretary
May 20, 2021Tax withholding−42,120$0.86$36.22K301,422
Kelly Culwell
Chief Medical Officer
May 20, 2021Tax withholding−42,061$0.86$36.17K273,390
Russell Barrans
Chief Commercial Officer
May 20, 2021Tax withholding−31,480$0.86$27.07K450,372
Saundra L. Pelletier
Chief Executive Officer, Director
Mar 9, 2021Buy+45,249$2.28$103.17K906,137
Russell Barrans
Chief Commercial Officer
Feb 3, 2021Award+200,000––481,852
Justin J. File
Chief Financial Officer
Feb 3, 2021Award+200,000––458,168
Saundra L. Pelletier
Chief Executive Officer, Director
Feb 3, 2021Award+500,000––860,888
Kelly Culwell
Chief Medical Officer
Feb 3, 2021Award+200,000––315,451
Alexander A. Fitzpatrick
General Counsel and Secretary
Feb 3, 2021Award+200,000––343,542
Justin J. File
Chief Financial Officer
Nov 17, 2020Buy+7,760$2.17$16.84K258,168
Alexander A. Fitzpatrick
General Counsel and Secretary
Nov 17, 2020Buy+9,090$2.20$20.00K143,542
Russell Barrans
Chief Commercial Officer
Sep 11, 2020Buy+3,000$2.08$6.24K279,052
Russell Barrans
Chief Commercial Officer
Sep 10, 2020Buy+1,000$2.71$2.71K276,052
Saundra L. Pelletier
Chief Executive Officer, Director
Sep 8, 2020Sale−122,500$3.26$399.35K360,888
Russell Barrans
Chief Commercial Officer
Jul 8, 2020Tax withholding−20,381$3.30$67.26K275,052
Lisa Dale Rarick
Director
Jun 17, 2020Buy+5,250$2.99$15.70K5,250
William Walmsley Hall
Director
Jun 15, 2020Buy+5,000$2.85$14.25K5,000
William Walmsley Hall
Director
Jun 15, 2020Buy+5,000$2.85$14.25K5,000
Kim P. Kamdar
Director, 10% owner
Jun 12, 2020Buy+5,000$2.94$14.70K9,287
Justin J. File
Chief Financial Officer
Jun 12, 2020Buy+8,500$3.14$26.69K250,408
Ltd. Invesco
10% owner
Jun 5, 2020Buy+857,143$3.50$3.00M13,226,532
Russell Barrans
Chief Commercial Officer
Jun 5, 2020Tax withholding−15,455$3.31$51.16K293,509
Kelly Culwell
Chief Medical Officer
Jun 5, 2020Tax withholding−31,548$3.31$104.42K115,451
Alexander A. Fitzpatrick
General Counsel and Secretary
Jun 5, 2020Tax withholding−31,590$3.31$104.56K134,452
Saundra L. Pelletier
Chief Executive Officer, Director
Jun 5, 2020Tax withholding−85,620$3.31$283.40K479,085
Justin J. File
Chief Financial Officer
Jun 5, 2020Tax withholding−42,810$3.31$141.70K237,605
Fund Solutions Ltd Link
10% owner
Jun 4, 2020Sale−9,138,504$0.23$2.10M0
Research Corp Acacia
10% owner
Jun 4, 2020Sale−9,138,504$3.21$29.33M1,000
Ltd. Invesco
10% owner
May 26, 2020Sale−65$5.98$38912,369,389
Ltd. Invesco
10% owner
May 26, 2020Sale−73,814$5.79$427.38K12,369,454
Russell Barrans
Chief Commercial Officer
May 22, 2020Tax withholding−19,474$4.99$97.18K308,964
Kelly Culwell
Chief Medical Officer
May 22, 2020Tax withholding−39,435$4.99$196.78K146,999
Alexander A. Fitzpatrick
General Counsel and Secretary
May 22, 2020Tax withholding−39,487$4.99$197.04K166,042
Justin J. File
Chief Financial Officer
May 22, 2020Tax withholding−42,262$4.99$210.89K280,415
Saundra L. Pelletier
Chief Executive Officer, Director
May 22, 2020Tax withholding−84,525$4.99$421.78K564,705
Pdl Biopharma, Inc.
10% owner
May 21, 2020Other−13,333,334––0

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.